oxaprozin has been researched along with Shoulder Pain in 4 studies
Oxaprozin: An oxazole-propionic acid derivative, cyclooxygenase inhibitor, and non-steroidal anti-inflammatory drug that is used in the treatment of pain and inflammation associated with of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; and ARTHRITIS, JUVENILE.
oxaprozin : A monocarboxylic acid that is a propionic acid derivative having a 4,5-diphenyl-1,3-oxazol-2-yl substituent at position 3. It is non-steroidal anti-inflammatory drug commonly used to relieve the pain and inflammatory responses associated with osteoarthritis and rheumatoid arthritis.
Shoulder Pain: Unilateral or bilateral pain of the shoulder. It is often caused by physical activities such as work or sports participation, but may also be pathologic in origin.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of oxaprozin in comparison with diclofenac in patients with periarthritis pain of the shoulder previously unsuccessfully treated with nonsteroidal anti-inflammatory drugs other than diclofenac and oxaprozin." | 9.11 | Oxaprozin versus diclofenac in NSAID-refractory periarthritis pain of the shoulder. ( Heller, B; Tarricone, R, 2004) |
| "To evaluate the efficacy and safety of oxaprozin in comparison with diclofenac in patients with periarthritis pain of the shoulder previously unsuccessfully treated with nonsteroidal anti-inflammatory drugs other than diclofenac and oxaprozin." | 5.11 | Oxaprozin versus diclofenac in NSAID-refractory periarthritis pain of the shoulder. ( Heller, B; Tarricone, R, 2004) |
| "Oxaprozin has a high oral bioavailability (95%), with peak plasma concentrations at 3 to 5 hours after dosing." | 1.32 | Oxaprozin: kinetic and dynamic profile in the treatment of pain. ( Kean, WF, 2004) |
| "Oxaprozin has been shown to cause mild elevation of liver enzymes in clinical studies." | 1.30 | Oxaprozin-induced symptomatic hepatotoxicity. ( Kethu, SR; Lansford, CL; Rukkannagari, S, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kean, WF | 1 |
| Heller, B | 1 |
| Tarricone, R | 1 |
| Carucci, JA | 1 |
| Cohen, DE | 1 |
| Kethu, SR | 1 |
| Rukkannagari, S | 1 |
| Lansford, CL | 1 |
1 trial available for oxaprozin and Shoulder Pain
| Article | Year |
|---|---|
Oxaprozin versus diclofenac in NSAID-refractory periarthritis pain of the shoulder.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Diclofenac; Female; Humans; Male; Middle Aged; Oxaprozin; P | 2004 |
3 other studies available for oxaprozin and Shoulder Pain
| Article | Year |
|---|---|
Oxaprozin: kinetic and dynamic profile in the treatment of pain.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Diclofenac; Humans; Oxaprozin; Periar | 2004 |
Toxic epidermal necrolysis following treatment with oxaprozin.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Drug Eruptions; Humans; Male; Oxaprozin; Propionates; | 1999 |
Oxaprozin-induced symptomatic hepatotoxicity.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Chemical and Drug Induced Liver Injury; Fema | 1999 |